I am a board-certified radiologist with fellowship training in cross-sectional imaging, a technique that uses ultrasound, CT, or MRI to create cross-sectional views of the body. This approach is widely used to diagnose and monitor the treatment of different types of cancers. My particular area of expertise is imaging gynecologic cancers. Advanced imaging technologies enable me to detect and characterize masses in the pelvic area that are causing symptoms suggestive of cancer, and I can provide gynecologic surgeons with valuable information about the extent of disease before surgery.
Using a combination of tumor markers and modern imaging modalities, I collaborate with gynecologic oncologists to monitor treatment and detect early recurrence of gynecologic cancers.
Since joining Memorial Sloan Kettering a decade ago, I have been an active participant in regular multidisciplinary gynecologic treatment and planning conferences. Members of the gynecology disease management team, including gynecologic surgeons, gynecologic oncologists, radiation oncologists, radiologists, and pathologists, collaboratively develop individualized treatment plans for our patients.
I participate in many local and national multicenter clinical trials investigating the effectiveness of different anticancer medications for genitourinary tract cancers. The goal of these studies is to evaluate patients’ responses to these drugs using modern multidetector computer tomography, which allows precise measurements of tumors before and after treatment. My independent research is focused on detection, staging, and prognosis of ovarian cancer.
I give lectures at meetings of national and regional imaging societies such as the Society of Genitourinary Radiologists and New York Roentgen Ray Society.
- Clinical Expertise: Cross-Sectional Body Imaging
- Languages Spoken: English
- Education: MD, State Medical Academy (Russia)
- Residencies: Long Island College Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Diagnostic Radiology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more